Pennant Group earnings release, August 5, 2026

Pennant Group, Inc. (PNTG) · Form 8-K, Item 2.02 · Filed · SEC filing

Pennant Reports Second Quarter 2026 Results

Conference Call and Webcast scheduled for tomorrow, August 6, 2026 at 10:00 am MT

EAGLE, Idaho – August 5, 2026 (GLOBE NEWSWIRE) - The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the

Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.25 for the second quarter of 2026. Pennant also reported adjusted diluted earnings per share of $0.36 for the quarter

(1).

Second Quarter Highlights

▪ Total revenue for the second quarter was $298.0 million, an increase of $78.5 million or 35.8% over the prior year quarter;

▪ Net income for the second quarter was $9.1 million, an increase of $2.0 million or 28.2% over the prior year quarter;

▪ Adjusted net income for the second quarter was $12.8 million, an increase of $3.4 million or 36.5% over the prior year quarter;

▪ Consolidated Adjusted EBITDAR for the second quarter was $37.6 million, an increase of $9.4 million or 33.3% over the prior year quarter;

▪ Consolidated Adjusted EBITDA for the second quarter was $24.3 million, an increase of $7.9 million or 48.2% over the prior year quarter;

▪ Consolidated Adjusted EBITDA prior to NCI for the second quarter was $26.1 million, an increase of $8.8 million or 51.0% over the prior year quarter;

▪ Home Health and Hospice Services segment revenue for the second quarter was $237.8 million, an increase of $71.8 million or 43.2% over the prior year quarter;

▪ Home Health and Hospice Services segment adjusted EBITDAR from operations for the second quarter was $41.0 million, an increase of $13.3 million or 47.9% over the prior year quarter; segment adjusted EBITDA from operations for the second quarter was $37.7 million, an increase of $12.3 million or 48.2% over the prior year quarter; and segment adjusted EBITDA from operations prior to NCI for the second quarter $39.6 million, an increase of $13.2 million or 50.0% over the prior year quarter;

▪ Total home health admissions for the second quarter were 28,947, an increase of 11,115 or 62.3% over the prior year quarter; same store home health admissions for the second quarter were 17,854, an increase of 1,573 or 9.7% over the prior year quarter; total Medicare home health admissions for the second quarter were 11,916, an increase of 4,936 or 70.7% over the prior year quarter; same store Medicare home health admissions for the second quarter were 7,372, an increase of 883 or 13.6% over the prior year quarter;¹

▪ Hospice average daily census for the second quarter was 5,477, an increase of 1,568 or 40.1% compared to the prior year quarter; same store hospice average daily census for the second quarter was 4,089, an increase of 397 or 10.8% compared to the prior year quarter;

▪ Senior Living Services segment revenue for the second quarter was $60.2 million, an increase of $6.7 million or 12.6% over the prior year quarter; average occupancy for the second quarter was 78.9%, an increase of 10 basis points over the prior year quarter, same store average occupancy for the second quarter was 81.6%, an increase of 150 basis points over the prior year quarter, average monthly revenue per occupied room for the second quarter was $5,392, an increase of $204 or 3.9% over the prior year quarter, and same store average monthly revenue per occupied room for the second quarter was $5,413, an increase of $282 or 5.5% over the prior year quarter;

▪ Senior Living segment adjusted EBITDAR from operations for the second quarter was $16.0 million, an increase of $1.2 million or 7.9% over the prior year quarter; and segment adjusted EBITDA from operations for the second quarter was $5.8 million, an increase of $0.7 million or 13.2% over the prior year quarter.

Operating Results

“Pennant delivered another strong quarter, putting us on pace to exceed the top end of our original full year guidance,” said Brent Guerisoli, the Company’s Chief Executive Officer. “We are driving operational excellence across both segments, including at our recently-acquired operations in the southeast, even as we complete their integration. That process is unfolding ahead of our expectations, and we are now transitioning the two largest waves of operations, which we expect to fully complete by the middle of the fourth quarter.”

“Our segments continue to deliver healthy growth,” said John Gochnour, the Company’s Chief Operating Officer. “We have been focused on operational excellence at every level, which is producing compelling clinical results and record financial performance. In the home health and hospice segment, years of rigorous investment and innovation helped us weather the challenging reimbursement environment of the last few years and now positions us to benefit from the more stable payment landscape that appears ahead. On the senior living side, our focus on finding and developing great leaders has enabled us to pursue numerous attractive acquisitions year-to-date, build out local care continuums, and continue to grow our real estate portfolio.”

A discussion of the Company’s use of Non-GAAP financial measures is set forth below. Reconciliations of net income to EBITDA, adjusted EBITDAR, adjusted EBITDA, and adjusted EBITDA prior to NCI, as well as a reconciliation of GAAP earnings per share, net income to adjusted net earnings per share and adjusted net income, appear in the financial data portion of this release. More complete information is contained in the Company’s Form 10-Q for the three and six months ended June 30, 2026, which will be filed with the SEC and will be available to be viewed on the Company’s website at www.pennantgroup.com.

2026 Guidance Update... (truncated) year 2026 adjusted EBITDA is anticipated to be between $94.4 million and $98.0 million; and full year adjusted EBITDA prior to NCI is anticipated to be $101.5 million to $105.1 million.

The Company’s updated 2026 annual guidance is based on diluted weighted average shares outstanding of approximately 37.0 million and a 26.0% effective tax rate. The guidance includes among other things, certain costs relating to our transition services agreement with UnitedHealth, reimbursement rate adjustments and no unannounced acquisitions. It excludes net income attributable to noncontrolling interest, the tax-effected costs at start-up operations, share-based compensation, acquisition-related costs, and gain (loss) on disposition of assets and impairments.²

Lynette Walbom, the Company’s Chief Financial Officer, also stated, “We believe providing updated annual adjusted consolidated EBITDA guidance in addition to updated annual revenue and adjusted earnings per share guidance is helpful to understanding our expectations for our business and operational cash flow. This updated guidance reflects management’s expectations based on year-to-date performance and current operating conditions. Our guidance includes revenue in the range of $196.0 to $198.0 million, adjusted EBITDA in the range of $17.0 to $18.6 million, and adjusted EBITDA prior to NCI of $20.8 to $22.5 million relating to these former UnitedHealth and Amedisys assets.”

Conference Call

A live webcast will be held tomorrow, August 6, 2026 at 10:00 a.m. Mountain time (12:00 p.m. Eastern time) to discuss Pennant’s second quarter 2026 financial results. To listen to the webcast, or to view any financial or statistical information required by SEC Regulation G, please visit the Investors Relations section of Pennant’s website at https://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website.

About Pennant

The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 175 home health and hospice agencies and 69 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Financial statements

Income Statement

Three Months Ended June 30, — (unaudited, in thousands, except for per-share amounts)

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Revenue297,984219,501583,348429,343
Expense:Cost of services242,635177,275475,297346,020
Expense:Rent—cost of services13,42811,92526,52623,640
Expense:General and administrative expense21,61417,59741,30132,437
Expense:Depreciation and amortization3,1122,2245,7284,116
Expense:Loss (gain) on disposition of property and equipment, net9-1,0489-1,048
Expense:Total expenses280,798207,973548,861405,165
Expense:Income from operations17,18611,52834,48724,178
Other expense, net:Other income626255480186
Other expense, net:Income from equity method investment370370
Other expense, net:Interest expense, net-3,348-1,204-6,416-2,409
Other expense, net:Other expense, net-2,352-949-5,566-2,223
Other expense, net:Income before provision for income taxes14,83410,57928,92121,955
Other expense, net:Provision for income taxes3,9362,5987,7305,452
Other expense, net:Net income10,8987,98121,19116,503
Other expense, net:Less: Net income attributable to noncontrolling interest1,8168963,5901,643
Other expense, net:Net income attributable to The Pennant Group, Inc.9,0827,08517,60114,860
Earnings per share:Basic0.260.210.510.43
Earnings per share:Diluted0.250.20.490.42
Weighted average common shares outstanding:Basic34,83534,52934,78134,500
Weighted average common shares outstanding:Diluted35,95735,37235,85735,284

Income Statement

Three Months Ended June 30, — The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:

Three Months Ended June 30, – 2026 – Revenue DollarsThree Months Ended June 30, – 2026 – Revenue PercentageThree Months Ended June 30, – 2025 – Revenue DollarsThree Months Ended June 30, – 2025 – Revenue Percentage
Home health and hospice servicesHome health119,44740.179,19436.1
Home health and hospice servicesHospice103,58034.873,77033.6
Home health and hospice servicesHome care and other(a)14,7434.913,0565.9
Home health and hospice servicesTotal home health and hospice services237,77079.8166,02075.6
Home health and hospice servicesSenior living services60,21420.253,48124.4
Home health and hospice servicesTotal revenue297,984100219,501100

Income Statement

Six Months Ended June 30, — The following table sets forth our total revenue by segment and as a percentage of total revenue for the periods indicated:

Six Months Ended June 30, – 2026 – Revenue DollarsSix Months Ended June 30, – 2026 – Revenue PercentageSix Months Ended June 30, – 2025 – Revenue DollarsSix Months Ended June 30, – 2025 – Revenue Percentage
Home health and hospice servicesHome health234,86340.3153,31235.7
Home health and hospice servicesHospice202,73934.8144,35633.6
Home health and hospice servicesHome care and other(a)29,2574.928,2226.6
Home health and hospice servicesTotal home health and hospice services466,85980325,89075.9
Home health and hospice servicesSenior living services116,48920103,45324.1
Home health and hospice servicesTotal revenue583,348100429,343100

Income Statement

Three Months Ended June 30, — The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:

Three Months Ended June 30, – 2026 – Revenue DollarsThree Months Ended June 30, – 2026 – Revenue Percentage2025 – Revenue DollarsRevenue Percentage
Revenue:Medicare151,65150.9103,82147.3
Revenue:Medicaid39,81513.430,79814
Revenue:Subtotal191,46664.3134,61961.3
Revenue:Managed care47,92516.130,61913.9
Revenue:Private and other(a)58,59319.654,26324.8
Revenue:Total revenue297,984100219,501100

Income Statement

Six Months Ended June 30, — The following table presents our total revenue by payor source as a percentage of total revenue for the periods indicated:

Six Months Ended June 30, – 2026 – Revenue DollarsSix Months Ended June 30, – 2026 – Revenue Percentage2025 – Revenue DollarsRevenue Percentage
Revenue:Medicare296,50950.8204,94647.8
Revenue:Medicaid77,13613.258,13613.5
Revenue:Subtotal373,64564263,08261.3
Revenue:Managed care93,65216.161,33314.3
Revenue:Private and other(a)116,05119.9104,92824.4
Revenue:Total revenue583,348100429,343100

Income Statement

Three Months Ended June 30, — The following table reconciles net income to Non-GAAP net income for the periods presented:

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net income attributable to The Pennant Group, Inc.9,0827,08517,60114,860
Non-GAAP adjustmentsCosts at start-up operations(a)312-6185132
Non-GAAP adjustmentsShare-based compensation expense(b)3,0572,2125,6464,379
Non-GAAP adjustmentsAcquisition related costs(c)3502,1667042,438
Non-GAAP adjustmentsActivities associated with transitioning operations(d)-982-907
Non-GAAP adjustmentsTransition services costs(e)1,2571,664
Non-GAAP adjustmentsUnusual, non-recurring or redundant charges(f)1667

Income Statement

Three Months Ended June 30,

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Consolidated net income10,8987,98121,19116,503
Less: Net income attributable to noncontrolling interest1,8168963,5901,643
Add: Provision for income taxes3,9362,5987,7305,452
Net interest expense3,3481,2046,4162,409
Depreciation and amortization3,1122,2245,7284,116
Consolidated EBITDA19,47813,11137,47526,837
Adjustments to Consolidated EBITDAAdd: Start-up operations(a)58-158353-80
Adjustments to Consolidated EBITDAShare-based compensation expense(b)3,0572,2125,6464,379
Adjustments to Consolidated EBITDAAcquisition related costs(c)3502,1667042,438
Adjustments to Consolidated EBITDAActivities associated with transitioning operations(d)-1,036-1,016
Adjustments to Consolidated EBITDATransition services costs(e)1,2571,664
Adjustments to Consolidated EBITDAOther unusual, non-recurring, or redundant charges(f)1667
Adjustments to Consolidated EBITDARent related to items (a) and (d) above6764135123
Adjustments to Consolidated EBITDAConsolidated Adjusted EBITDA24,26716,37545,97732,748
Adjustments to Consolidated EBITDARent—cost of services13,42811,92526,52623,640
Adjustments to Consolidated EBITDARent related to items (a) and (d) above-67-64-135-123
Adjustments to Consolidated EBITDAAdjusted rent—cost of services13,36111,86126,39123,517
Adjustments to Consolidated EBITDAConsolidated Adjusted EBITDAR(g)37,62872,368

Income Statement

Three Months Ended June 30,

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net income attributable to The Pennant Group, Inc.9,0827,08517,60114,860
Add: Provision for income taxes3,9362,5987,7305,452
Net interest expense3,3481,2046,4162,409
Depreciation and amortization3,1122,2245,7284,116
Consolidated EBITDA19,47813,11137,47526,837
Adjustments to Consolidated EBITDAAdd: Start-up operations(a)58-158353-80
Adjustments to Consolidated EBITDAShare-based compensation expense(b)3,0572,2125,6464,379
Adjustments to Consolidated EBITDAAcquisition related costs(c)3502,1667042,438
Adjustments to Consolidated EBITDAActivities associated with transitioning operations(d)-1,036-1,016
Adjustments to Consolidated EBITDATransition services costs(e)1,2571,664
Adjustments to Consolidated EBITDAOther unusual, non-recurring, or redundant charges(f)1667
Adjustments to Consolidated EBITDARent related to items (a) and (d) above6764135123
Adjustments to Consolidated EBITDAConsolidated Adjusted EBITDA24,26716,37545,97732,748
Adjustments to Consolidated EBITDAAdd: Net Income attributable to noncontrolling interest (“NCI”)1,8168963,5901,643
Adjustments to Consolidated EBITDAConsolidated Adjusted EBITDA prior to NCI26,08317,27149,56734,391

Income Statement

Three Months Ended June 30, — The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:

Three Months Ended June 30, – 2026Three Months Ended June 30, – 2025Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Segment Adjusted EBITDAR from Operations(a)56,91342,471109,97884,194
Less: Unallocated corporate expenses19,28514,23537,61027,929
Depreciation and amortization3,1122,2245,7284,116
Rent—cost of services13,42811,92526,52623,640
Income from equity method investment370370
Other income626255480186
Adjustments to Segment EBITDAR from Operations:Less: Start-up operations(b)58-158353-80
Adjustments to Segment EBITDAR from Operations:Share-based compensation expense(c)3,0572,2125,6464,379
Adjustments to Segment EBITDAR from Operations:Acquisition related costs(d)3502,1667042,438
Adjustments to Segment EBITDAR from Operations:Activities associated with transitioning operations(e)-1,036-1,016
Adjustments to Segment EBITDAR from Operations:Transition services costs(f)1,2571,664
Adjustments to Segment EBITDAR from Operations:Other unusual, non-recurring, or redundant charges(g)1667
Adjustments to Segment EBITDAR from Operations:Add: Net income attributable to noncontrolling interest1,8168963,5901,643
Adjustments to Segment EBITDAR from Operations:Income from operations17,18611,52834,48724,178

Balance Sheet

June 30, 2026 — (in thousands, except par value)

June 30, 2026December 31, 2025
Current assets:Cash15,27317,024
Current assets:Accounts receivable—less allowance for credit losses of $766 and $681, at June 30, 2026 and December 31, 2025, respectively133,182123,109
Current assets:Prepaid expenses and other current assets35,13627,273
Current assets:Total current assets183,591167,406

Cash Flow

Six Months Ended June 30, — The following table presents selected data from our condensed consolidated statements of cash flows for the periods presented:

Six Months Ended June 30, – 2026Six Months Ended June 30, – 2025
Net cash provided by operating activities18,42513,414
Net cash used in investing activities-45,301-60,355
Net cash provided by financing activities25,12537,080
Net decrease in cash-1,751-9,861
Cash beginning of period17,02424,246
Cash end of period15,27314,385
Full release

This press release contains, and the related conference call and webcast will include, forward-looking statements that are based on management’s current expectations, assumptions and beliefs about its business, financial performance, operating results, the industry in which it operates and other future events. Forward-looking statements can often be identified by words such as "anticipates," "expects," "intends," "plans," "predicts," "believes," "seeks," "estimates," "may," "will," "should," "would," "could," "potential," "continue," "ongoing," similar expressions, and variations or negatives of these words. These forward-looking statements include, but are not limited to, statements regarding growth prospects, future operating and financial performance, and acquisition activities. They are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to materially and adversely differ from those expressed in any forward-looking statement.

These risks and uncertainties relate to the company’s business, its industry and its common stock and include: reduced prices and reimbursement rates for its services; its ability to acquire, develop, manage or improve operations, its ability to manage its increasing borrowing costs as it incurs additional indebtedness to fund the acquisition and development of operations; its ability to access capital on a cost-effective basis to continue to successfully implement its growth strategy; its operating margins and profitability could suffer if it is unable to grow and manage effectively its increasing number of operations; competition from other companies in the acquisition, development and operation of facilities; its ability to defend claims and lawsuits, including professional liability claims alleging that our services resulted in personal injury, and other regulatory-related claims; and the application of existing or proposed government regulations, or the adoption of new laws and regulations, that could limit its business operations, require it to incur significant expenditures or limit its ability to relocate its operations if necessary. Readers should not place undue reliance on any forward-looking statements and are encouraged to review the company’s periodic filings with the Securities and Exchange Commission, including its Form 10-Q and/or 10-K, for a more complete discussion of the risks and other factors that could affect Pennant’s business,³ prospects and any forward-looking statements. Except as required by the federal securities laws, Pennant does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changing circumstances or any other reason after the date of this press release.

Contact Information

Investor Relations

The Pennant Group, Inc.

(208) 401-1400 ir@pennantgroup.com

SOURCE: The Pennant Group, Inc.⁴

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Pennant Group earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.